期刊文献+

左乙拉西坦治疗小儿癫100例疗效与安全性随访观察 被引量:8

Follow-Up Study on Efficacy and Safety of Levetiracetam Therapy on Epilepsy in 100 Children
原文传递
导出
摘要 目的观察左乙拉西坦(LEV)单药或添加治疗不同类型小儿癫的临床疗效和安全性。方法选取100例于山西省儿童医院小儿神经内科专科门诊2008年8月-2010年10月收治的应用LEV单药或添加治疗的癫患儿为研究对象,采用开放性自身对照随访研究方法。LEV给药起始剂量为10 mg.kg-1.d-1,分2次口服,每周增加上述剂量1次,3~4周增加至目标剂量20~40 mg.kg-1.d-1,随访6~24个月,以发作频率减少的百分率作为疗效判定标准,观察治疗前后发作频率变化、脑电图改变,并记录治疗过程中不良反应的发生情况,以评价其安全性。结果入选癫患儿100例,失访4例。发作完全控制49例(占51.0%);有效27例(占28.1%);无效17例(占17.8%);加重3例(占3.1%)。总有效率为79.1%。脑电图明显改善者8例。14例(14.6%)患儿出现包括情绪异常,7例(7.3%)出现乏力,6例(6.3%)出现嗜睡,1例(1.0%)出现皮疹等不良反应。未发现严重过敏及血液系统抑制、肝肾功能异常等不良反应。2例因不良反应停药。结论 LEV治疗小儿各种类型癫具有良好的疗效和安全性,是一个值得推广的广谱抗癫药物。 Objective To observe the efficacy and safety of levetiracetam (LEV) therapy on different types of epilepsies in children. Methods One hundred cases of children with epilepsy receiving LEV therapy from Shanxi Children's Hospital between Aug. 2008 and Oct. 2010 were investigated in the subject. The method of self - controlled and open - label research was performed. The LEV treatment initiated at the dose of 10 mg·kg^-1· d^-1, which was divided into twice daily, the same amounts were added continuously once a week, until the objective dose of 20 - 40 mg · kg^ -1·d ^-1 within 3 - 4 weeks. Observation lasted for 6 - 24 months. Following the judgment standard of the efficacy : Per- centage reduction of seizure frequency,the efficacy and electroencephalogram (EEG) changes were assessed ,safety was evaluated by recor- ding adverse events. Results Among 100 children ,96 patients were followed up,49 cases (51.0%) achieved seizure -free, 27 children (28.1% ) had at least 50% reduction in seizures but not 100% , 17 cases( 17.8% ) had inefficacy and 3 cases(3.1% ) had aggravation. The total effective rate was 79.1%. EEG improvemented in 8 cases. The adverse events happened in few cases, including mood and behavioral changes (14 cases, 14.6% ), asthenia (7 cases ,7.3 % ), somnolence (6 cases, 6.3 % ), and skin rashes (1 case, 1.0% ). Two cases withdrew the treatment for side effects. Conclusion Levetiracetam is of well efficacy and safety for children with various types of epilepsy, should be wildly applied to epileptic children.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2011年第21期1661-1663,共3页 Journal of Applied Clinical Pediatrics
关键词 癫 左乙拉西坦 疗效 安全性 儿童 epilepsy levetiracetam efficacy safety child
  • 相关文献

参考文献17

  • 1刘金玲,黄希顺,黄圣明.拉莫三嗪对丙戊酸类药物治疗无效癫的疗效[J].实用儿科临床杂志,2011,26(10):787-788. 被引量:4
  • 2杨自金.托吡酯添加治疗难治性癫的疗效[J].实用儿科临床杂志,2010,25(18):1436-1437. 被引量:1
  • 3Goldenberg M. Overview of drugs used for epilepsy and seizures : Etiology diagnosis, and treatment [ J 1. PT,2010,35 ( 7 ) : 392 - 415.
  • 4高志杰,姜玉武.左乙拉西坦单药治疗小儿癫癎的疗效和安全性随访研究[J].中国当代儿科杂志,2008,10(6):711-714. 被引量:33
  • 5Ramatani G, Ikonomidou C, Walter B, et al. Levetiracetam : Safty and ef- ficacy in neonatal seizures[ J]. Eur J Paediatr Neuro1,2011,15 ( 1 ) : 1 - 7.
  • 6Kaminski RM, Matagne A, Patsalos PN, et al. Benefit of combination therapy in epilepsy : A review of the preclinieal evidence with levetiraee- tam [ J ]. Epilepsia,2009,50 (3) : 387 - 397.
  • 7Vliet EA, Aronica E, Redeker S, et al. Decreased expression of synaptic vesicle protein 2A,the binding site for levetiracetam, during epileptoge- nesis and chronic epilepsy [ J ]. Epilepsia,2009,50 ( 3 ) :422 - 433.
  • 8Rafal MK, Michel G, Karine L,et al. Proepileptie phenotype of SV2A- deficient mice is associated with reduced anticonvulsant efficacy of le,m- tiracetam [ J]. Epilepsia ,2009,50(7 ) : 1729 - 1740.
  • 9田增民,卢旺盛,吴朝晖,林鸿,王红,王福莉.脑深部电极监测抗癫药物对脑深部核团脑电图的影响[J].中国微侵袭神经外科杂志,2009,14(6):260-261. 被引量:2
  • 10Verrotti A, D'Adamo E, Parisi P, et al. Levetiracetam in childhood epi- lepsy [ J ]. Pediatr Drugs,2010,12 ( 3 ) : 177 - 186.

二级参考文献44

共引文献34

同被引文献60

  • 1陈春富,郎森阳,王湘庆,傅国庆,夏程.病毒性脑炎急性期继发性全身性强直-阵挛发作的危险因素分析[J].卒中与神经疾病,2006,13(3):149-152. 被引量:3
  • 2丁庆明,任连坤.抗癫痫新药左乙拉西坦的临床应用和安全性[J].药物不良反应杂志,2007,9(4):295-301. 被引量:40
  • 3Gallentine WB,Hunnicutt AS, Husain AM.Levetiracetam in children with refractory status epilepticus[J]. Epilepsy Behav, 2009,14(1):215.
  • 4庞保东,王玉珍,刘寅.拉莫三嗪、左乙拉西坦治疗儿童难治性癫痫疗效对照研究[C].中华医学会第十五次全国儿科学术大会论文汇编(上册),2012:393-394.
  • 5Carunchio I,Pieri M, Ciotti MT,et al. Modulation of AMPA receptors in cultured cortical neurons induced by the antiepilep- tic drug levetiraeetam [J]. Epilepsia,2007,48(4) :654.
  • 6Kaminski RM,Gillard M,Leclercq K,et al. Proepileptic pheno- type of SV2A--deficient mice is associated with reduced anticon- vulsant efficacy of fovetiracetam [J]. Epilepsia, 2009,50 : 1729- 1740.
  • 7Krief P, Li Kan, Maytal J. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age [J]. J Child Neurol, 2008,23(5) :582-584.
  • 8Wu T, Chen CC, Chen TC,et al. Clinical eficacy and cognitive and neuropsychologieal efects of levetiraeetam in epilepsy: an open-label muhicenter study [J]. Epilepsy Behav, 2009,16 (3) : 468-474.
  • 9Gallentine W B, Hunnicutt A S, Husain A M. Levetiracetam in chil- dren with refractory status epilepticus [ J]. Epilepsy Behav ,2009 ,14 ( 1 ) :215.
  • 10Carunchio I, Pieri M, Ciotti M T, et al. Modulation of AMPA recep- tors in cultured cortical neurons induced by the antiepileptic drug levetiracetam [ J 1. Epilepsia, 2007,48 (4) : 654-662.

引证文献8

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部